Alyeska Investment Group’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-11,184
| Closed | -$75K | – | 451 |
|
|
2017
Q3 | $75K | Buy |
11,184
+200
| +2% | +$1.34K | ﹤0.01% | 421 |
|
|
2017
Q2 | $81K | Sell |
10,984
-332
| -3% | -$2.45K | ﹤0.01% | 419 |
|
|
2017
Q1 | $88K | Sell |
11,316
-167
| -1% | -$1.3K | ﹤0.01% | 444 |
|
|
2016
Q4 | $81K | Sell |
11,483
-35
| -0.3% | -$247 | ﹤0.01% | 434 |
|
|
2016
Q3 | $74K | Buy |
11,518
+459
| +4% | +$2.95K | ﹤0.01% | 425 |
|
|
2016
Q2 | $103K | Buy |
11,059
+224
| +2% | +$2.09K | ﹤0.01% | 406 |
|
|
2016
Q1 | $98K | Buy |
10,835
+2,649
| +32% | +$24K | ﹤0.01% | 365 |
|
|
2015
Q4 | $415K | Buy |
8,186
+383
| +5% | +$19.4K | ﹤0.01% | 348 |
|
|
2015
Q3 | $390K | Buy |
7,803
+670
| +9% | +$33.5K | ﹤0.01% | 424 |
|
|
2015
Q2 | $714K | Buy |
+7,133
| New | +$714K | 0.01% | 408 |
|